Sakar Healthcare Dividende
Zukünftiges Wachstum Kriterienprüfungen 0/6
Sakar Healthcare does not have a record of paying a dividend.
Wichtige Informationen
n/a
Dividendenausschüttung
-2.3%
Rückkaufsrendite
| Gesamte Aktionärsrendite | -2.3% |
| Zukünftige Dividendenrendite | n/a |
| Wachstum der Dividende | n/a |
| Nächster Dividendenzahlungstermin | n/a |
| Ex-Dividendendatum | n/a |
| Dividende pro Aktie | n/a |
| Ausschüttungsquote | n/a |
Aktuelle Dividendenentwicklung
Keine Aktualisierungen
Recent updates
Sakar Healthcare's (NSE:SAKAR) Anemic Earnings Might Be Worse Than You Think
Oct 30
Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?
Dec 28Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?
Aug 05Is Sakar Healthcare (NSE:SAKAR) A Risky Investment?
Mar 29Here's Why Sakar Healthcare (NSE:SAKAR) Has Caught The Eye Of Investors
Jan 31Is Sakar Healthcare (NSE:SAKAR) Using Too Much Debt?
Dec 01Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet
Jul 13Sakar Healthcare (NSE:SAKAR) Has A Somewhat Strained Balance Sheet
Mar 26With EPS Growth And More, Sakar Healthcare (NSE:SAKAR) Is Interesting
Jul 01Here's Why I Think Sakar Healthcare (NSE:SAKAR) Might Deserve Your Attention Today
Mar 23Insider Buying: The Sakar Healthcare Limited (NSE:SAKAR) Chairman & MD Just Bought 7.1% More Shares
Mar 02Has Sakar Healthcare Limited's (NSE:SAKAR) Impressive Stock Performance Got Anything to Do With Its Fundamentals?
Feb 08Does Sakar Healthcare (NSE:SAKAR) Have A Healthy Balance Sheet?
Jan 10Here's Why I Think Sakar Healthcare (NSE:SAKAR) Is An Interesting Stock
Dec 14Should You Rely On Sakar Healthcare's (NSE:SAKAR) Earnings Growth?
Nov 22
Stabilität und Wachstum des Zahlungsverkehrs
Rufe Dividendendaten ab
Stabile Dividende: Insufficient data to determine if SAKAR's dividends per share have been stable in the past.
Wachsende Dividende: Insufficient data to determine if SAKAR's dividend payments have been increasing.
Dividendenrendite im Vergleich zum Markt
| Sakar Healthcare Dividendenrendite im Vergleich zum Markt |
|---|
| Segment | Dividendenrendite |
|---|---|
| Unternehmen (SAKAR) | n/a |
| Untere 25 % des Marktes (IN) | 0.2% |
| Markt Top 25 % (IN) | 1.1% |
| Branchendurchschnitt (Pharmaceuticals) | 0.7% |
| Analystenprognose (SAKAR) (bis zu 3 Jahre) | n/a |
Bemerkenswerte Dividende: Unable to evaluate SAKAR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
Hohe Dividende: Unable to evaluate SAKAR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Gewinnausschüttung an die Aktionäre
Abdeckung der Erträge: Insufficient data to calculate SAKAR's payout ratio to determine if its dividend payments are covered by earnings.
Barausschüttung an die Aktionäre
Cashflow-Deckung: Unable to calculate sustainability of dividends as SAKAR has not reported any payouts.